AnaptysBio, Inc. (ANAB) Misses Q2 EPS by 67c
Tweet
Share
E-mail
Get Alerts ANAB Hot Sheet
Join SI Premium – FREE
AnaptysBio, Inc. (NASDAQ: ANAB) reported Q2 EPS of ($1.71), $0.67 worse than the analyst estimate of ($1.04). Revenue for the quarter came in at $10.97 million versus the consensus estimate of $22.76 million.
For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral
- Barclays Reinstates EQT AB (EQT:SS) (EQBBF) at Equalweight
- Grizzly Discoveries closes private placement raising $349,044
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
